BIOX / Bioceres Crop Solutions Corp. - Pemfailan SEC, Laporan Tahunan, Penyata Proksi

Bioceres Crop Solutions Corp.
US ˙ NasdaqGS ˙ KYG1117K1141

Statistik Asas
LEI 549300SBSSIZUVSY4U27
CIK 1769484
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Bioceres Crop Solutions Corp.
SEC Filings (Chronological Order)
Halaman ini menyediakan senarai kronologi lengkap bagi Pemfailan SEC, tidak termasuk pemfailan pemilikan yang kami sediakan di tempat lain.
September 2, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2025 Commission File Number: 001

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2025 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argenti

August 21, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of August 2025 Commission File Number: 001-38

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of August 2025 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina

June 20, 2025 EX-99.1

Bioceres Crop Solutions Announces Changes to Board of Directors

Exhibit 99.1 Bioceres Crop Solutions Announces Changes to Board of Directors ROSARIO, Argentina - 06/20/2025 - Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (the “Company”), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, today announced changes to the composition of its B

June 20, 2025 EX-99.1

BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of March 31, 2025 and June 30, 2024, and for the three- and nine-month periods ended March 31, 2025 and 2024.

Table of Contents Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of March 31, 2025 and June 30, 2024, and for the three- and nine-month periods ended March 31, 2025 and 2024. Table of Contents INDEX Unaudited interim condensed consolidated financial statements as of March 31, 2025 and June 30, 2024, and for the three- and nine-month peri

June 20, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of June 2025 Commission File Number: 001-3883

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of June 2025 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (A

June 20, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of June 2025 Commission File Number: 001-3883

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of June 2025 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (A

June 20, 2025 EX-99.1

FIRST AMENDMENT TO NOTE PURCHASE AGREEMENT AND NOTES

Exhibit 99.1 FIRST AMENDMENT TO NOTE PURCHASE AGREEMENT AND NOTES This First Amendment to Note Purchase Agreement and the Notes (this “Agreement”), dated as of June 18, 2025, is made by and among Jasper Lake Ventures One LLC, Redwood Enhanced Income Corp. and Liminality Partners LP (collectively, the "Purchasers" and each a “Purchaser”), Bioceres Crop Solutions Corp., an exempted company incorpora

June 20, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of June 2025 Commission File Number: 001-3883

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of June 2025 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (A

June 20, 2025 EX-99.2

FIRST AMENDMENT TO NOTE PURCHASE AGREEMENT AND NOTES

Exhibit 99.2 FIRST AMENDMENT TO NOTE PURCHASE AGREEMENT AND NOTES This First Amendment to Note Purchase Agreement and the Notes (this “Agreement”), dated as of June 18, 2025, is made by and among Solel-Bioceres SPV, L.P. (the “Purchaser”), Bioceres Crop Solutions Corp., an exempted company incorporated under the laws of the Cayman Islands (the “Issuer”) and Wilmington Savings Fund Society, FSB, in

May 21, 2025 EX-99.1

Contact Bioceres Crop Solutions

Exhibit 99.1 Bioceres Crop Solutions Bioceres Crop Solutions Reports Fiscal Third Quarter 2025 Financial and Operational Results Total revenues in 3Q25 were $60.6 million 3Q25 net loss was $1.6 million and Adjusted EBITDA1 was $9.0 million ROSARIO, Argentina – May 21, 2025 – Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity s

May 21, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of May 2025 Commission File Number: 001-38836

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of May 2025 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (Ad

March 11, 2025 EX-99.1

Bioceres Crop Solutions Announces EPA Registration of Rinotec Insecticide and Nematicide Platform, a Game-Changing Solution for Integrated Pest Management

Exhibit 99.1 Bioceres Crop Solutions Announces EPA Registration of Rinotec Insecticide and Nematicide Platform, a Game-Changing Solution for Integrated Pest Management ROSARIO, Argentina—March 11, 2025 (BUSINESS WIRE) —Bioceres Crop Solutions (NASDAQ: BIOX), a leading global provider of sustainable crop productivity solutions, and ProFarm Group, a subsidiary of BIOX, today announced that their inn

March 11, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of March 2025 Commission File Number: 001-388

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of March 2025 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (

March 6, 2025 EX-99.1

Bioceres Crop Solutions Secures Patent Protection for HB4 Wheat in the U.S. Until 2042

Exhibit 99.1 Bioceres Crop Solutions Secures Patent Protection for HB4 Wheat in the U.S. Until 2042 ROSARIO, Argentina—March 5, 2025 (BUSINESS WIRE) —Bioceres Crop Solutions Corp. (NASDAQ: BIOX), announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its first event-specific patent covering the HB4 Wheat, IND-ØØ412-7. This approval

March 6, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of March 2025 Commission File Number: 001-388

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of March 2025 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (

February 28, 2025 EX-99.1

BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of December 31, 2024 and June 30, 2024, and for the three- and six-month periods ended December 31, 2024 and 2023.

Table of Contents Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of December 31, 2024 and June 30, 2024, and for the three- and six-month periods ended December 31, 2024 and 2023. Table of Contents INDEX Unaudited interim condensed consolidated financial statements as of December 31, 2024 and June 30, 2024, and for the three- and six-mon

February 28, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2025 Commission File Number: 001-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2025 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin

February 14, 2025 CORRESP

* * * * * * * *

Linklaters LLP 1290 Avenue of the Americas New York, NY 10104 Telephone (+1) 212 903 9000 Facsimile (+1) 212 903 9100 matthew.

February 12, 2025 EX-99.1

Bioceres Crop Solutions

Exhibit 99.1 Bioceres Crop Solutions Bioceres Crop Solutions Reports Fiscal Second Quarter 2025 Financial and Operational Results Total revenues in 2Q25 were $106.7 million 2Q25 net income was $0.6 million and Adjusted EBITDA1 was $15.4 million ROSARIO, Argentina – February 11, 2025 – Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of prod

February 12, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2025 Commission File Number: 001-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2025 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin

February 6, 2025 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2025 Commission File Number: 001-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2025 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin

February 6, 2025 EX-99.1

Bioceres Crop Solutions Updates Second Fiscal Quarter 2025 Expectations

Exhibit 99.1 Bioceres Crop Solutions Updates Second Fiscal Quarter 2025 Expectations Rosario, Argentina – February 5, 2025 – Bioceres Crop Solutions Corp. (NASDAQ: BIOX) today provided preliminary revenues, gross profit and adjusted EBITDA for the fiscal second quarter, ended December 31, 2024. Second quarter revenues are expected to be approximately $105 million, with gross profit of $45 million

January 22, 2025 424B3

Bioceres Crop Solutions Corp. (incorporated in the Cayman Islands)

TABLE OF CONTENTS  Filed Pursuant to Rule 424(b)(3)  Registration No. 333-284195 PROSPECTUS Bioceres Crop Solutions Corp. (incorporated in the Cayman Islands) This prospectus relates to the resale, from time to time, of (i) 8,434 ordinary shares, par value $0.0001 per share (“Ordinary Shares”) of Bioceres Crop Solutions Corp., previously registered pursuant to our registration on Form F-1 (File No

January 17, 2025 F-3/A

As filed with the Securities and Exchange Commission on January 17, 2025

TABLE OF CONTENTS As filed with the Securities and Exchange Commission on January 17, 2025 Registration No.

January 17, 2025 CORRESP

January 17, 2025

January 17, 2025 U.S. Securities and Exchange Commission 100 F Street NE Washington, D.C. 20549 Re: Bioceres Crop Solutions Corp. (the “Company”) Acceleration Request for Registration Statement on Form F-3 (File No. 333-284195), as amended by Pre-Effective Amendment No. 1 Ladies and Gentlemen: Pursuant to Rules 460 and 461 under the Securities Act of 1933, as amended, the Company hereby requests t

January 10, 2025 F-3

As filed with the Securities and Exchange Commission on January 10, 2025

TABLE OF CONTENTS As filed with the Securities and Exchange Commission on January 10, 2025 Registration No.

January 10, 2025 EX-FILING FEES

Calculation of Filing Fee Tables Form F-3 (Form Type) Bioceres Crop Solutions Corp. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities

Exhibit 107 Calculation of Filing Fee Tables Form F-3 (Form Type) Bioceres Crop Solutions Corp.

December 2, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of December 2024 Commission File Number: 001-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of December 2024 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin

November 27, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2024 Commission File Number: 001-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2024 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin

November 27, 2024 EX-99.1

BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of September 30, 2024 and June 30, 2024, and for the three- month periods ended September 30, 2024 and 2023.

Table of Contents Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of September 30, 2024 and June 30, 2024, and for the three- month periods ended September 30, 2024 and 2023. Table of Contents INDEX Unaudited interim condensed consolidated financial statements as of September 30, 2024 and June 30, 2024, and for the three-month periods end

November 12, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2024 Commission File Number: 001-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2024 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin

November 12, 2024 EX-99.1

Bioceres Crop Solutions

Exhibit 99.1 Bioceres Crop Solutions Bioceres Crop Solutions Reports Fiscal First Quarter 2025 Financial and Operational Results Total revenues in 1Q25 were $93.3 million 1Q25 net loss1 was $5.3 million and Adjusted EBITDA1 was $8.5 million ROSARIO, Argentina – November 11, 2024 – Bioceres Crop Solutions Corp. (“Bioceres” or the “Company”) (NASDAQ: BIOX), a leader in the development and commercial

October 30, 2024 EX-97

NASDAQ EXECUTIVE REMUNERATION CLAWBACK POLICY

Exhibit 97 NASDAQ EXECUTIVE REMUNERATION CLAWBACK POLICY 1 PURPOSE 1.1 The purpose of this policy (this “Nasdaq Clawback Policy”) is to set out the basis for the mandatory recovery of erroneously awarded Incentive-Based Compensation (as defined below) from Executives (as defined below) of Bioceres Crop Solutions Corp. (the “Company”, together with its subsidiaries, the “Group“) in the event of a R

October 30, 2024 EX-13.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Exhibit 13.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Bioceres Crop Solutions Corp. (the “Company”) on Form 20-F for the year ended June 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certifies pursuant to 18

October 30, 2024 EX-13.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Bioceres Crop Solutions Corp. (the “Company”) on Form 20-F for the year ended June 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certifies pursuant to 18

October 30, 2024 EX-15.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Exhibit 15.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (Registration No.333-272280) and Form S-8 (Registration Nos. 333-255635, 333-266333 and 333-271941) of our report dated October 30, 2024 relating to the financial statements and the effectiveness of internal control over financial repo

October 30, 2024 20-F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2024 OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SEC

October 30, 2024 EX-12.1

CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

Exhibit 12.1 CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Federico Trucco, certify that: 1. I have reviewed this annual report on Form 20-F of Bioceres Crop Solutions Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omi

October 30, 2024 EX-12.2

CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

Exhibit 12.2 CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Enrique López Lecube, certify that: 1. I have reviewed this annual report on Form 20-F of Bioceres Crop Solutions Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact o

October 23, 2024 SC 13G

BIOX / Bioceres Crop Solutions Corp. / Fourth Sail Capital LP - FOURTH SAIL CAPITAL LP Passive Investment

SC 13G 1 bioxonnasdaq101124.htm FOURTH SAIL CAPITAL LP UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Bioceres Crop Solutions Corp. (Name of Issuer) Ordinary Shares (Title of Class of Securities) G1117K114 (CUSIP Number) September 30, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriate bo

October 3, 2024 EX-99.1

Convening Notice to the 2024 Annual General Meeting to be held on October 24, 2024 at 10:00 a.m. EDT at 1290 Avenue of the Americas, New York, NY 10104

Exhibit 99.1 www.biocerescrops.com Ocampo 210 bis Predio CCT Rosario (2000) Rosario, Santa Fe, Argentina T: +1 602 930 7022 E: [email protected] October 3, 2024 Dear Shareholder, You are cordially invited to attend the 2024 Annual General Meeting (the “Annual General Meeting”) of Bioceres Crop Solutions Corp. (the “Company”) to be held at 10:00 a.m. EDT on October 24, 2024 at the Compan

October 3, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of October 2024 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of October 2024 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina

September 30, 2024 EX-99.1

BIOCERES CROP SOLUTIONS CORP. Consolidated financial statements as of June 30, 2024 and 2023 and for the years ended June 30, 2024, 2023 and 2022.

Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Consolidated financial statements as of June 30, 2024 and 2023 and for the years ended June 30, 2024, 2023 and 2022. INDEX Consolidated financial statements as of June 30, 2024 and 2023 and for the years ended June 30, 2024, 2023 and 2022. Report of independent registered public accounting firm F-3 Consolidated statements of financial position F-5 Consoli

September 30, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2024 Commission File Number: 001

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2024 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argenti

September 20, 2024 SC 13D/A

BIOX / Bioceres Crop Solutions Corp. / Bioceres Group PLC - SC 13D/A Activist Investment

SC 13D/A 1 tm2424494d1sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 10)* Bioceres Crop Solutions Corp. (Name of Issuer) Ordinary Shares, $0.0001 par value (Title of Class of Securities) G1117K 114 (CUSIP Number) Gloria Montaron Estrada Bioceres Group PLC Highdown House, Yeoman Way,

September 10, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2024 Commission File Number: 001

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2024 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argenti

September 10, 2024 EX-99.1

Contact Bioceres Crop Solutions

Exhibit 99.1 Bioceres Crop Solutions Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2024 Financial and Operational Results Revenues up 18% in 4Q24, consolidating annual revenues of $465 million FY24 GAAP net income at $6.2 million and adjusted EBITDA1 at $81.4 million ROSARIO, Argentina – September 9, 2024 – Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in

August 28, 2024 EX-99.1

Bioceres Crop Solutions receives green light for cultivation of drought tolerant hb4 wheat in the United StATES

Exhibit 99.1 Bioceres Crop Solutions receives green light for cultivation of drought tolerant hb4 wheat in the United StATES ROSARIO, Argentina—August 28, 2024 (BUSINESS WIRE) —Bioceres Crop Solutions Corp. (NASDAQ: BIOX) announced today that the United States Department of Agriculture (USDA) has favorably concluded its Regulatory Status Review (RSR) for HB4 wheat technology. The announcement can

August 28, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of August 2024 Commission File Number: 001-38

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of August 2024 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina

July 1, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of July 2024 Commission File Number: 001-3883

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of July 2024 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (A

May 29, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of May 2024 Commission File Number: 001-38836

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of May 2024 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (Ad

May 29, 2024 EX-99.1

BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of March 31, 2024 and June 30, 2023, and for the three and nine month periods ended March 31, 2024 and 2023.

Table of Contents Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of March 31, 2024 and June 30, 2023, and for the three and nine month periods ended March 31, 2024 and 2023. Table of Contents INDEX Unaudited interim condensed consolidated financial statements as of March 31, 2024 and June 30, 2023, and for the three and nine month period

May 14, 2024 EX-99.1

FISCAL THIRD QUARTER Financial and Operating Results

Exhibit 99.1 FISCAL THIRD QUARTER 2024 Financial and Operating Results BIOCERES CROP SOLUTIONS THIRD QUARTER 2024 Bioceres Crop Solutions Reports Fiscal Third Quarter 2024 Financial and Operational Results Total revenues in 3Q24 were $84.0 million 3Q24 GAAP net income was $9.8 million and adjusted EBITDA1 was $21.1 million ROSARIO, Argentina – May 13, 2024 – Bioceres Crop Solutions Corp. (Bioceres

May 14, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of May 2024 Commission File Number: 001-38836

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of May 2024 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (Ad

May 7, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of May 2024 Commission File Number: 001-38836

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of May 2024 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (Ad

May 7, 2024 EX-99.1

Bioceres Crop Solutions Announces Brazil’s Approval of New Generation Bio-Insecticide

Exhibit 99.1 Bioceres Crop Solutions Announces Brazil’s Approval of New Generation Bio-Insecticide LONDRINA, Brazil—May 7, 2024 (BUSINESS WIRE) —Bioceres Crop Solutions Corp. (NASDAQ: BIOX), announced today the approval by Brazil’s Ministry of Agriculture and Livestock (MAPA- Ministério da Agricultura e Pecuária) of three new bio-insecticidal/bio-nematicidal solutions derived from inactivated cell

May 2, 2024 CORRESP

* * * * * * * *

Linklaters LLP 1290 Avenue of the Americas New York, NY 10104 Telephone (+1) 212 903 9000 Facsimile (+1) 212 903 9100 matthew.

April 11, 2024 CORRESP

* * * * * * * *

Linklaters LLP 1290 Avenue of the Americas New York, NY 10104 Telephone (+1) 212 903 9000 Facsimile (+1) 212 903 9100 matthew.

March 25, 2024 SC 13D/A

BIOX / Bioceres Crop Solutions Corp. / Bioceres Group PLC - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 9)* Bioceres Crop Solutions Corp. (Name of Issuer) Ordinary Shares, $0.0001 par value (Title of Class of Securities) G1117K 114 (CUSIP Number) Gloria Montaron Estrada Bioceres Group PLC Highdown House, Yeoman Way, Worthing, West Sussex, United Kingdom Tele

March 25, 2024 EX-99.1

Joint Filing Agreement

Exhibit 99.1 Joint Filing Agreement In accordance with Rule 13d-1(k) under the Securities and Exchange Act of 1934, the undersigned hereby agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the ordinary shares, $0.0001 par value, of Bioceres Crop Solutions Corp. and further agree that this joint filing agreement be incl

March 1, 2024 CORRESP

* * * * * * * * *

Linklaters LLP 1290 Avenue of the Americas New York, NY 10104 Telephone (+1) 212 903 9000 Facsimile (+1) 212 903 9100 matthew.

February 28, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2024 Commission File Number: 001-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2024 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin

February 28, 2024 EX-99.1

BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of December 31, 2023 and June 30, 2023, and for the three and six month periods ended December 31, 2023 and 2022.

Table of Contents Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of December 31, 2023 and June 30, 2023, and for the three and six month periods ended December 31, 2023 and 2022. Table of Contents INDEX Unaudited interim condensed consolidated financial statements as of December 31, 2023 and June 30, 2023, and for the three and six month

February 14, 2024 SC 13G/A

BIOX / Bioceres Crop Solutions Corp. / Solel Partners LP - SC 13G/A Passive Investment

SC 13G/A 1 ef20021543sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) * BIOCERES CROP SOLUTIONS CORP. ORDINARY SHARES, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) G1117K114 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check t

February 9, 2024 EX-99.1

FISCAL SECOND QUARTER Financial and Operating Results

Exhibit 99.1 FISCAL SECOND QUARTER 2024 Financial and Operating Results BIOCERES CROP SOLUTIONS SECOND QUARTER 2024 Bioceres Crop Solutions Reports Fiscal Second Quarter 2024 Financial and Operational Results 2Q24 revenues at $140.2 million, 49% higher YoY GAAP net income at $1.2 million, and adjusted EBITDA1 at $24.1 million ROSARIO, Argentina – February 8, 2024 – Bioceres Crop Solutions Corp. (B

February 9, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2024 Commission File Number: 001-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2024 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin

January 24, 2024 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of January 2024 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of January 2024 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina

January 24, 2024 EX-99.1

Bioceres Crop Solutions Releases Scope 1 & 2 Greenhouse Gas Emissions Report

Exhibit 99.1 Bioceres Crop Solutions Releases Scope 1 & 2 Greenhouse Gas Emissions Report ROSARIO, Argentina—January 23, 2024 (BUSINESS WIRE) —Bioceres Crop Solutions Corp. (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced today the release of the

November 29, 2023 EX-99.1

BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of September 30, 2023 and June 30, 2023, and for the three-month periods ended September 30, 2023 and 2022.

Table of Contents Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of September 30, 2023 and June 30, 2023, and for the three-month periods ended September 30, 2023 and 2022. Table of Contents INDEX Unaudited interim condensed consolidated financial statements as of September 30, 2023 and June 30, 2023, and for the three-month periods ende

November 29, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2023 Commission File Number: 001-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin

November 29, 2023 EX-99.1

Unaudited Consolidated Statement of Financial Position

Exhibit 99.1 Unaudited Consolidated Statement of Financial Position (Figures in million of U.S. dollars) ASSETS 09/30/2023 06/30/2023 CURRENT ASSETS Cash and cash equivalents 28.4 48.1 Other financial assets 14.6 12.1 Trade receivables 186.3 158.0 Other receivables 24.9 28.8 Income and minimum presumed income taxes recoverable 2.0 9.4 Inventories 138.1 140.4 Biological assets 1.1 0.1 Total current

November 29, 2023 6-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K/A (Amendment No. 1) Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2023 Commissi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K/A (Amendment No. 1) Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province o

November 14, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2023 Commission File Number: 001-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin

November 14, 2023 EX-13.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Exhibit 13.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Bioceres Crop Solutions Corp. (the “Company”) on Form 20-F for the year ended June 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certifies pursuant to 18

November 14, 2023 EX-13.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Bioceres Crop Solutions Corp. (the “Company”) on Form 20-F for the year ended June 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certifies pursuant to 18

November 14, 2023 20-F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

November 14, 2023 EX-12.2

CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

Exhibit 12.2 CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Enrique López Lecube, certify that: 1. I have reviewed this annual report on Form 20-F of Bioceres Crop Solutions Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact o

November 14, 2023 EX-99.1

BIOCERES CROP SOLUTIONS FIRST QUARTER 2024 1 Bioceres Crop Solutions Reports Fiscal First Quarter 2024 Financial and Operational Results 1Q24 revenues at $116.6 million, and adjusted EBITDA at $16.3 million Groundbreaking patent obtained in key produ

Exhibit 99.1 FISCAL FIRST QUARTER 2024 Financial and Operating Results BIOCERES CROP SOLUTIONS FIRST QUARTER 2024 1 Bioceres Crop Solutions Reports Fiscal First Quarter 2024 Financial and Operational Results 1Q24 revenues at $116.6 million, and adjusted EBITDA at $16.3 million Groundbreaking patent obtained in key product category ROSARIO, Argentina – November 13, 2023 – Bioceres Crop Solutions Co

November 14, 2023 EX-12.1

CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

Exhibit 12.1 CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Federico Trucco, certify that: 1. I have reviewed this annual report on Form 20-F of Bioceres Crop Solutions Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omi

November 14, 2023 EX-15.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Exhibit 15.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (Registration No.333-272280) and Form S-8 (Registration Nos. 333-255635, 333-266333 and 333-271941) of our report dated November 14, 2023 relating to the financial statements and the effectiveness of internal control over financial rep

October 30, 2023 NT 20-F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ¨ Form 10-K x Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form N-SAR ¨ Form N-CSR SEC FILE NUMBER 001-38405 CUSIP NUMBER G1117K114 For Period Ended: June 30, 2023 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report o

October 12, 2023 6-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K/A (Amendment No. 1) Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of October 2023 Commissio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K/A (Amendment No. 1) Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of October 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of

October 12, 2023 EX-99.1

Convening Notice to the 2023 Annual General Meeting to be held on October 27, 2023 at 10:00 a.m. EDT at 1290 Avenue of the Americas, New York, NY 10104

Exhibit 99.1 www.biocerescrops.com Ocampo 210 bis Predio CCT Rosario (2000) Rosario, Santa Fe, Argentina T: +1 602 930 7022 E: [email protected] / [email protected] October 12, 2023 Dear Shareholder, You are cordially invited to attend the 2023 Annual General Meeting (the “Annual General Meeting”) of Bioceres Crop Solutions Corp. (the “Company”) to be held at 10:00 a.m.

October 11, 2023 EX-99.1

Convening Notice to the 2023 Annual General Meeting to be held on October 27, 2023 at 10:00 a.m. EDT at 1290 Avenue of the Americas, New York, NY 10104

Exhibit 99.1 www.biocerescrops.com Ocampo 210 bis Predio CCT Rosario (2000) Rosario, Santa Fe, Argentina T: +1 602 930 7022 E: [email protected] / [email protected] October 11, 2023 Dear Shareholder, You are cordially invited to attend the 2023 Annual General Meeting (the “Annual General Meeting”) of Bioceres Crop Solutions Corp. (the “Company”) to be held at 10:00 a.m.

October 11, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of October 2023 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of October 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina

September 29, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argenti

September 29, 2023 EX-99.1

BIOCERES CROP SOLUTIONS CORP. Consolidated financial statements as of and for the years ended June 30, 2023, 2022 and 2021.

Table of Contents Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Consolidated financial statements as of and for the years ended June 30, 2023, 2022 and 2021. Table of Contents INDEX Consolidated financial statements as of and for the years ended June 30, 2023, 2022 and 2021. Report of independent registered public accounting firm F-2 Consolidated statements of financial position F-3 Consolidated stat

September 11, 2023 EX-99.1

BIOCERES CROP SOLUTIONS FOURTH QUARTER 2023 1 Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full Year 2023 Financial and Operational Results FY23 revenues up 25% and Adjusted EBITDA at $81.1 million ROSARIO, Argentina – September 11, 2023

Exhibit 99.1 FISCAL FOURTH QUARTER & FULL YEAR 2023 Financial and Operating Results BIOCERES CROP SOLUTIONS FOURTH QUARTER 2023 1 Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full Year 2023 Financial and Operational Results FY23 revenues up 25% and Adjusted EBITDA at $81.1 million ROSARIO, Argentina – September 11, 2023 – Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a lead

September 11, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2023 Commission File Number: 001

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argenti

July 18, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of July 2023 Commission File Number: 001-3883

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of July 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (A

July 18, 2023 EX-99.1

Corteva Agriscience and Bioceres Crop Solutions to Advance Availability of Biologicals in Europe The Companies Signed an Exclusive Agreement on Distribution of Innovative Bioinsecticide

Exhibit 99.1 Corteva Agriscience and Bioceres Crop Solutions to Advance Availability of Biologicals in Europe The Companies Signed an Exclusive Agreement on Distribution of Innovative Bioinsecticide GENEVA, Switzerland; ROSARIO, Argentina ‒ July 18, 2023 ‒ Corteva Agriscience (Corteva) (NYSE: CTVA) and Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), announced today that they have entered

June 8, 2023 424B3

Bioceres Crop Solutions Corp. (incorporated in the Cayman Islands)

TABLE OF CONTENTS  Filed Pursuant to Rule 424(b)(3)  Registration Statement No. 333-272280 PROSPECTUS Bioceres Crop Solutions Corp. (incorporated in the Cayman Islands) This prospectus relates to the resale, from time to time, of (i) 14,759 ordinary shares, par value $0.0001 per share (“Ordinary Shares”) of Bioceres Crop Solutions Corp., previously registered pursuant to our registration on Form F

June 6, 2023 CORRESP

June 6, 2023

June 6, 2023 U.S. Securities and Exchange Commission 100 F Street NE Washington, D.C. 20549 Re: Bioceres Crop Solutions Corp. (the “Company”) Acceleration Request for Registration Statement on Form F-3 (File No. 333-272280) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the effective date of the above-referenced Registratio

May 30, 2023 F-3

As filed with the Securities and Exchange Commission on May 30, 2023

TABLE OF CONTENTS As filed with the Securities and Exchange Commission on May 30, 2023 Registration No.

May 30, 2023 EX-FILING FEES

Filing Fee Table.

Exhibit 107 Calculation of Filing Fee Tables Form F-3 (Form Type) Bioceres Crop Solutions Corp.

May 24, 2023 EX-99.1

BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of March 31, 2023 and June 30, 2022, and for the three and nine-month periods ended March 31, 2023, and 2022.

Table of Contents Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of March 31, 2023 and June 30, 2022, and for the three and nine-month periods ended March 31, 2023, and 2022. Table of Contents INDEX Unaudited interim condensed consolidated financial statements as of March 31, 2023, June 30, 2022 and for the three and nine-month periods e

May 24, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of May 2023 Commission File Number: 001-38836

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of May 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (Ad

May 15, 2023 EX-FILING FEES

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) Bioceres Crop Solutions Corp.

May 15, 2023 EX-99.1

2023 Omnibus Equity Incentive Plan.

Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. 2023 OMNIBUS EQUITY INCENTIVE PLAN WHEREAS, the Bioceres Crop Solutions Corp. 2023 Omnibus Equity Incentive Plan (this “Plan”) was established in order to provide an incentive to eligible employees of Bioceres Crop Solutions Corp., an exempted company incorporated under the laws of Cayman Islands (the “Company”) and its Subsidiaries; WHEREAS, the Company

May 15, 2023 S-8

As filed with the Securities and Exchange Commission on May 15, 2023

As filed with the Securities and Exchange Commission on May 15, 2023 Registration No.

May 11, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of May 2023 Commission File Number: 001-38836

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of May 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (Ad

May 11, 2023 EX-99.1

FISCAL THIRD QUARTER Financial and Operating Results

Exhibit 99.1 FISCAL THIRD QUARTER 2023 Financial and Operating Results BIOCERES CROP SOLUTIONS THIRD QUARTER 2023 Bioceres Crop Solutions Reports Fiscal Third Quarter 2023 Financial and Operational Results Revenues increased 33% compared with 3Q22 pro forma numbers LTM adjusted EBITDA reached $85.3 million Brazil HB4 initiatives advancing favorably on the back of full regulatory approval for wheat

April 5, 2023 EX-99.1

Bioceres Crop Solutions Releases FY22 Sustainability Report

Exhibit 99.1 Bioceres Crop Solutions Releases FY22 Sustainability Report ROSARIO, Argentina – April 3, 2023 – Bioceres Crop Solutions Corp. (NASDAQ: BIOX), a fully integrated provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, is pleased to announce the release of the company’s inaugural FY22 Sustainability Report, entitled: Each Step

April 5, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of April 2023 Commission File Number: 001-388

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of April 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (

March 27, 2023 6-K

our Report on Form 6-K (File No. 001-38836), furnished to the SEC on March 27, 2023

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of March 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (

March 27, 2023 EX-99.1

Selected Unaudited Pro Forma Condensed Combined Financial Information

Exhibit 99.1 Selected Unaudited Pro Forma Condensed Combined Financial Information The following unaudited pro forma combined financial information has been derived by the application of pro forma adjustments to the historical financial statements of BIOX, which were presented to give effect to the merger. The unaudited pro forma combined financial information has used the acquisition method of ac

February 28, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2023 Commission File Number: 001-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin

February 28, 2023 EX-99.1

BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of December 31, 2022 and June 30, 2022, and for the three and six month periods ended December 31, 2022, and 2021.

Table of Contents Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of December 31, 2022 and June 30, 2022, and for the three and six month periods ended December 31, 2022, and 2021. Table of Contents INDEX Unaudited interim condensed consolidated financial statements as of December 31, 2022, June 30, 2022 and for the three and six month pe

February 14, 2023 SC 13G

BIOX / Bioceres Crop Solutions Corp. / Solel Partners LP - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* BIOCERES CROP SOLUTIONS CORP. ORDINARY SHARES, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) G1117K114 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pu

February 9, 2023 EX-99.1

BIOCERES CROP SOLUTIONS SECOND QUARTER 2023 1 Bioceres Crop Solutions Reports Fiscal Second Quarter 2023 Financial and Operational Results Severe drought in Argentina temporarily interrupted growth trajectory; decline in Argentina partially offset by

Exhibit 99.1 FISCAL SECOND QUARTER 2023 Financial and Operating Results BIOCERES CROP SOLUTIONS SECOND QUARTER 2023 1 Bioceres Crop Solutions Reports Fiscal Second Quarter 2023 Financial and Operational Results Severe drought in Argentina temporarily interrupted growth trajectory; decline in Argentina partially offset by higher sales in North America HB4 Wheat outperformed top commercial varieties

February 9, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2023 Commission File Number: 001-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin

February 9, 2023 6-K

our Report on Form 6-K (File No. 001-38836), furnished to the SEC on February 9, 2023

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin

January 25, 2023 EX-1

JOINT FILING AGREEMENT

EX-1 2 ex1.htm EXHIBIT 1 EXHIBIT 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(f) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of this Schedule 13G (including amendments thereto) with respect to the Common Stock of Bioceres Crop Solutions Corp. and further agree that this Joint Filing Agreement be includ

January 25, 2023 SC 13G

BIOX / Bioceres Crop Solutions Corp. / ARDSLEY ADVISORY PARTNERS LP - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Bioceres Crop Solutions Corp. (Name of Issuer) Common Stock (Title of Class of Securities) G1117K114 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is

January 25, 2023 EX-2

IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP

EX-2 3 ex2.htm EXHIBIT 2 EXHIBIT 2 IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP ARDSLEY ADVISORY PARTNERS LP ARDSLEY ADVISORY PARTNERS GP LLC ARDSLEY PARTNERS I GP LLC PHILLIP J. HEMPLEMAN ARDSLEY PARTNERS RENEWABLE ENERGY FUND, L.P.

November 29, 2022 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2022 Commission File Number: 001-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin

November 29, 2022 EX-99.1

BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of September 30, 2022 and June 30, 2022, and for the three-month periods ended September 30, 2022, and 2021.

Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of September 30, 2022 and June 30, 2022, and for the three-month periods ended September 30, 2022, and 2021. INDEX Unaudited interim condensed consolidated financial statements as of September 30, 2022, June 30, 2022 and for the three-month periods ended September 30, 2022 and 2021. Unaudite

November 18, 2022 SC 13G/A

BIOX / Bioceres Crop Solutions Corp. / DRACO Capital Investment Management Co Ltd Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.

November 18, 2022 424B3

Bioceres Crop Solutions Corp. (incorporated in the Cayman Islands)

PROSPECTUS Filed Pursuant to Rule 424(b)(3) Registration No. 333-268144 Bioceres Crop Solutions Corp. (incorporated in the Cayman Islands) This prospectus relates to the resale, from time to time, of (i) 4,755,684 ordinary shares, par value $0.0001 per share (?ordinary shares?) of Bioceres Crop Solutions Corp., (ii) 14,759 ordinary shares previously registered pursuant to our registration on Form

November 17, 2022 SC 13D/A

BIOX / Bioceres Crop Solutions Corp. / Bioceres S.A. - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 8)* Bioceres Crop Solutions Corp. (Name of Issuer) Ordinary Shares, $0.0001 par value (Title of Class of Securities) G1117K 114 (CUSIP Number) Gloria Montaron Estrada Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina Telephone: +54 0341 4

November 14, 2022 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2022 Commission File Number: 001-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin

November 14, 2022 CORRESP

November 14, 2022

November 14, 2022 U.S. Securities and Exchange Commission 100 F Street NE Washington, D.C. 20549 Re: Bioceres Crop Solutions Corp. (the ?Company?) Acceleration Request for Registration Statement on Form F-3 (File No. 333-268144) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the effective date of the above-referenced Regist

November 14, 2022 EX-99.1

BIOCERES CROP SOLUTIONS F IRST QUARTER 202 3 1 Bioceres Crop Solutions Reports Fiscal F irst Quarter 202 3 Financial and Operational Results R evenues increased 7 1 % compared to 1Q22 pro forma numbers 1Q23 Adjusted EBITDA nearly doubled YoY , reach

Exhibit 99.1 FISCAL FIRST QUARTER 2023 Financial and Operating Results BIOCERES CROP SOLUTIONS F IRST QUARTER 202 3 1 Bioceres Crop Solutions Reports Fiscal F irst Quarter 202 3 Financial and Operational Results R evenues increased 7 1 % compared to 1Q22 pro forma numbers 1Q23 Adjusted EBITDA nearly doubled YoY , reach ing $73 million on an LTM basis after excluding HB4 pre - launch costs A nnounc

November 3, 2022 EX-FILING FEES

Filing Fee Table.

Exhibit 107 Calculation of Filing Fee Tables Form F-3 (Form Type) Bioceres Crop Solutions Corp.

November 3, 2022 F-3

Form F-3 (Registration No. 333-268144)

As filed with the Securities and Exchange Commission on November 3, 2022 Registration No.

November 2, 2022 S-8 POS

As filed with the Securities and Exchange Commission on November 2, 2022

As filed with the Securities and Exchange Commission on November 2, 2022 Registration No.

November 2, 2022 6-K

BIOX’s Report on Form 6-K (File No. 001-38836), filed with the SEC on November 2, 2022

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin

November 2, 2022 S-8 POS

Form S-8 (Registration Nos. 333-255635

As filed with the Securities and Exchange Commission on November 2, 2021 Registration No.

October 28, 2022 EX-13.1

18 U.S.C. SECTION 1350 - Section 906 - Certification of Chief Executive Officer

Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Bioceres Crop Solutions Corp. (the “Company”) on Form 20-F for the year ended June 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certifies pursuant to 18

October 28, 2022 EX-15.2

Consent of Marcum LLP, independent registered public accounting firm, with respect to Pro Farm’s consolidated financial statements

Exhibit 15.2 INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT We consent to the incorporation by reference in the Registration Statement of Bioceres Crop Solutions Corp. on Form 20-F, of our report, dated March 30, 2022, which includes an explanatory paragraph as to Pro Farm Group, Inc.’s (formerly known as Marrone Bio Innovations, Inc.) ability to continue as a going concern, with respect

October 28, 2022 EX-4.14

Registration Rights Agreement, dated as of August 5, 2022 (as amended, restated supplemented or otherwise modified from time to time in accordance with the terms hereof) by and among Bioceres Crop Solutions Corp. and each purchaser named therein

Exhibit 4.14 Registration Rights Agreement This Registration Rights Agreement, dated as of August 5, 2022 (as amended, restated, supplemented or otherwise modified from time to time in accordance with the terms hereof, this “Agreement”), is made by and among BIOCERES CROP SOLUTIONS CORP., a Cayman Islands exempted company (the “Company”), Jasper Lake Ventures One LLC (“Jasper”), Redwood Capital Ma

October 28, 2022 20-F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ◻ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ⌧ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2022 OR ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

October 28, 2022 EX-13.2

18 U.S.C. SECTION 1350 - Section 906 - Certification of Chief Financial Officer

Exhibit 13.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Bioceres Crop Solutions Corp. (the “Company”) on Form 20-F for the year ended June 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certifies pursuant to 18

October 28, 2022 EX-12.1

Rule 13a-14(a)/15d-14(a) -– Section 302 - Certification of Chief Executive Officer

Exhibit 12.1 CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Federico Trucco, certify that: 1. I have reviewed this annual report on Form 20-F of Bioceres Crop Solutions Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omi

October 28, 2022 EX-15.1

Consent of Price Waterhouse & Co. S.R.L., independent registered public accounting firm, with respect to Bioceres Crop Solutions Corp.’s consolidated financial statements

Exhibit 15.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-249770) and Form S-8 (No. 333-255635 and 333-266333) of Bioceres Crop Solutions Corp. of our report dated September 30, 2022 relating to the financial statements, which appears in this Form 20-F. /s/ Price Waterhouse & Co. S.R

October 28, 2022 EX-12.2

Rule 13a-14(a)/15d-14(a) -– Section 302 - Certification of Chief Financial Officer

Exhibit 12.2 CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Enrique López Lecube, certify that: 1. I have reviewed this annual report on Form 20-F of Bioceres Crop Solutions Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact o

October 3, 2022 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2022 Commission File Number: 001

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argenti

October 3, 2022 EX-99.1

BIOCERES CROP SOLUTIONS CORP. Consolidated financial statements as of and for the years ended June 30, 2022, 2021 and 2020.

Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Consolidated financial statements as of and for the years ended June 30, 2022, 2021 and 2020. INDEX Consolidated financial statements as of and for the years ended June 30, 2022, 2021 and 2020. Report of independent registered public accounting firm F-3 Consolidated statements of financial position F-4 Consolidated statements of comprehensive income F-6 C

September 30, 2022 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2022 Commission File Number: 001

6-K 1 tm2226809d26k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosa

September 30, 2022 EX-99.1

[This page has been intentionally left blank.]

Exhibit 99.1 www.biocerescrops.com Ocampo 210 bis Predio CCT Rosario (2000) Rosario, Santa Fe, Argentina T: +1 602 930 7022 E: [email protected] / [email protected] September 30, 2022 Dear Shareholder, You are cordially invited to attend the 2022 Annual General Meeting (the ?Annual General Meeting?) of Bioceres Crop Solutions Corp. (the ?Company? or ?Bioceres Crop Soluti

September 16, 2022 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2022 Commission File Number: 001

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argenti

September 16, 2022 EX-99.1

Syngenta Seedcare and Bioceres Crop Solutions collaborate to bring innovative biological seed treatments to market

Exhibit 99.1 Media Release Syngenta AG Bioceres Crop Solutions Rosentalstrasse 67 Ocampo 210 bis, Predio CCT 4002 Basel, Switzerland Rosario 2000, Argentina www.syngenta.com www.biocerescrops.com Syngenta Seedcare and Bioceres Crop Solutions collaborate to bring innovative biological seed treatments to market ? Syngenta Seedcare to become the exclusive commercialization distributor of Bioceres?s b

September 8, 2022 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2022 Commission File Number: 001

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argenti

August 9, 2022 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of August 2022 Commission File Number: 001-38

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of August 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina

August 9, 2022 EX-99.1

Bioceres Crop Solutions Executed Previously Announced Financing Agreements for a Total Amount of $79 Million

Exhibit 99.1 Bioceres Crop Solutions Executed Previously Announced Financing Agreements for a Total Amount of $79 Million ROSARIO, Argentina ? August 9, 2022 ? Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (?Bioceres? or the ?Company?), a fully integrated provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, has finalized and executed th

August 8, 2022 EX-99.9

NOTE PURCHASE AGREEMENT by and among BIOCERES CROP SOLUTIONS CORP., as Issuer, Solel-Bioceres SPV, L.P., as an Initial Purchaser, THE OTHER HOLDERS FROM TIME TO TIME PARTY HERETO WILMINGTON SAVINGS FUND SOCIETY, FSB as Collateral Agent Dated as of Au

Exhibit 99.9 NOTE PURCHASE AGREEMENT by and among BIOCERES CROP SOLUTIONS CORP., as Issuer, Solel-Bioceres SPV, L.P., as an Initial Purchaser, THE OTHER HOLDERS FROM TIME TO TIME PARTY HERETO and WILMINGTON SAVINGS FUND SOCIETY, FSB as Collateral Agent Dated as of August 5, 2022 Article 1. DEFINITIONS 1 1.1 Definitions 1 1.2 Terms Generally 26 1.3 Accounting Terms 26 Article 2. PURCHASE AND SALE O

August 8, 2022 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of August 2022 Commission File Number: 001-38

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of August 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina

August 8, 2022 EX-99.10

NOTE PURCHASE AGREEMENT by and among BIOCERES CROP SOLUTIONS CORP., as Issuer, and THE INITIAL PURCHASERS AND OTHER HOLDERS FROM TIME TO TIME PARTY HERETO WILMINGTON SAVINGS FUND SOCIETY, FSB as Collateral Agent Dated as of August 5, 2022

Exhibit 99.10 Execution Version NOTE PURCHASE AGREEMENT by and among BIOCERES CROP SOLUTIONS CORP., as Issuer, and THE INITIAL PURCHASERS AND OTHER HOLDERS FROM TIME TO TIME PARTY HERETO and WILMINGTON SAVINGS FUND SOCIETY, FSB as Collateral Agent Dated as of August 5, 2022 Article 1. DEFINITIONS 1 1.1 Definitions 1 1.2 Terms Generally 27 1.3 Accounting Terms 27 Article 2. PURCHASE AND SALE OF THE

August 4, 2022 SC 13G/A

BIOX / Bioceres Crop Solutions Corp. / DRACO Capital Investment Management Co Ltd Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.

July 26, 2022 EX-99.1

2013 Stock Incentive Plan

Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. 2013 STOCK INCENTIVE PLAN, AS AMENDED (FORMERLY KNOWN AS THE ?MARRONE BIO INNOVATIONS, INC. 2013 STOCK INCENTIVE PLAN?) 1. Purposes of the Plan. The purposes of this Plan are to attract and retain the best available personnel, to provide additional incentives to Employees, Directors and Consultants and to promote the success of the Company?s business. 2.

July 26, 2022 S-8

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ? ? ? FORM?S-8 REGISTRATION STATEMENT? UNDER THE SECURITIES ACT OF 1933 ? ? ? Bioceres Crop Solutions Corp. (Exact name of registrant as specified in its charter) ? ? ? Cayman Islands (State or other jurisdiction of incorporation or organization) N/A (I.R.S. Employer Identification No.) ? Ocampo 210 bis, Predio CCT, Rosari

July 26, 2022 EX-FILING FEES

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) BIOCERES CROP SOLUTIONS CORP.

July 25, 2022 SC 13D/A

BIOX / Bioceres Crop Solutions Corp. / Bioceres S.A. - SC 13D/A Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 7)* Bioceres Crop Solutions Corp. (Name of Issuer) Ordinary Shares, $0.0001 par value (Title of Class of Securities) G1117K 114 (CUSIP Number) Gloria Montaron Estrada Executive Director Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (Name, Address a

July 25, 2022 EX-99.1

Joint Filing Agreement, by and among the Reporting Persons

Exhibit 99.1 Joint Filing Agreement In accordance with Rule 13d-1(k) under the Securities and Exchange Act of 1934, the undersigned hereby agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the ordinary shares, $0.0001 par value, of Bioceres Crop Solutions Corp. and further agree that this joint filing agreement be incl

July 15, 2022 SC 13G

BIOX / Bioceres Crop Solutions Corp. / Ospraie Ag Science LLC - SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Bioceres Crop Solutions Corp. (Name of Issuer) Ordinary Shares, par value US$0.0001 per share (Title of Class of Securities) G1117K114 (CUSIP Number) July 12, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to design

July 12, 2022 6-K

Form 6-K filed with the Commission on July 12, 2022

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of July 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (A

July 12, 2022 EX-99.1

Bioceres Crop Solutions completes merger with Marrone Bio, creating a global leader in sustainable agricultural solutions

Exhibit 99.1 Bioceres Crop Solutions completes merger with Marrone Bio, creating a global leader in sustainable agricultural solutions ROSARIO, Argentina ? July 12, 2022 ? Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (?Bioceres? or the ?Company?), a fully integrated provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, announced today t

June 27, 2022 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of June 2022 Commission File Number: 001-3883

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of June 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (A

June 27, 2022 EX-99.1

FDA Favorably Concludes HB4® Wheat Food and Feed Safety Evaluation

Exhibit 99.1 FDA Favorably Concludes HB4? Wheat Food and Feed Safety Evaluation ROSARIO, Argentina ? June 27, 2022 ? Bioceres Crop Solutions Corp. (?Bioceres? or the ?Company?) (NASDAQ: BIOX), a fully integrated provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, announced today that the U.S. Food and Drug Administration (FDA) has con

June 9, 2022 424B2

LETTER TO STOCKHOLDERS OF MARRONE BIO INNOVATIONS, INC.

TABLE OF CONTENTS ?Filed Pursuant to Rule 424(b)(2)? ?Registration No. 333-264806? LETTER TO STOCKHOLDERS OF MARRONE BIO INNOVATIONS, INC. Dear Stockholders: Marrone Bio Innovations, Inc. (which we refer to as ?MBI?) and Bioceres Crop Solutions Corp. (which we refer to as ?BIOX?) have entered into a merger agreement (which, as it may be amended from time to time, we refer to as the ?merger agreeme

June 6, 2022 EX-99.1

Consent of Houlihan Lokey

Exhibit 99.1 CONSENT OF HOULIHAN LOKEY CAPITAL, INC. June 6, 2022 Marrone Bio Innovations, Inc. 7780-420 Brier Creek Parkway Raleigh, NC 27617 Attention: Board of Directors RE: Proxy Statement of Marrone Bio Innovations, Inc. (?MBI?) / Prospectus of Bioceres Crop Solutions Corp. (?BIOX?) which forms part of Amendment No. 1 to the Registration Statement on Form F-4 of BIOX (the ?Registration Statem

June 6, 2022 EX-99.2

Form of Proxy Card for Marrone Bio Innovations, Inc.’s Stockholder Meeting.

Exhibit 99.2

June 6, 2022 CORRESP

June 6, 2022

June 6, 2022 U.S. Securities and Exchange Commission 100 F Street NE Washington, D.C. 20549 Re: Bioceres Crop Solutions Corp. (the ?Company?) Acceleration Request for Registration Statement on Form F-4, as amended (File No. 333-264806) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the effective date of the above-referenced

June 6, 2022 F-4/A

As filed with the Securities and Exchange Commission on June 6, 2022.

TABLE OF CONTENTS As filed with the Securities and Exchange Commission on June 6, 2022.

May 27, 2022 6-K

BIOX’s Form 6-K furnished to the SEC on May 27, 2022, containing BIOX’s unaudited interim condensed consolidated financial statements as of March 31, 2022 and June 30, 2021, and for the three-and nine-month periods ended March 31, 2022, and 2021 (which is referred to as the “BIOX Unaudited Interim Financial Statements”);

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of May 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (Ad

May 27, 2022 EX-99.1

BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of March 31, 2022 and June 30, 2021, and for the three-and nine-month periods ended March 31, 2022, and 2021.

Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of March 31, 2022 and June 30, 2021, and for the three-and nine-month periods ended March 31, 2022, and 2021. INDEX Unaudited interim condensed consolidated financial statements as of March 31, 2022, June 30, 2021 and for the three and nine-month periods ended March 31, 2022 and 2021. Unaudi

May 12, 2022 6-K

BIOX’s Form 6-K furnished to the SEC on May 12, 2022, containing management’s discussion and analysis of results for the period ended March 31, 2022;

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of May 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (Ad

May 9, 2022 EX-FILING FEES

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Tables Form F-4 (Form Type) BIOCERES CROP SOLUTIONS CORP.

May 9, 2022 EX-99.2

Form of Proxy Card for Marrone Bio Innovations, Inc.’s Stockholder Meeting.

Exhibit 99.2 MARRONE BIO INNOVATIONS, INC. 7780-420 Brier Creek Parkway, Raleigh, NC 27617 VOTE BY INTERNET ? Before The Meeting - Go www.proxyvote.com Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time on [?], 2022 for shares held directly and by 11:59 p.m. Eastern Time on [?], 2022 for shares held in a Plan. Have your

May 9, 2022 EX-99.1

Consent of Houlihan Lokey

Exhibit 99.1 CONSENT OF HOULIHAN LOKEY CAPITAL, INC. May 9, 2022 Marrone Bio Innovations, Inc. 7780-420 Brier Creek Parkway Raleigh, NC 27617 Attention: Board of Directors RE: Proxy Statement of Marrone Bio Innovations, Inc. (?MBI?) / Prospectus of Bioceres Crop Solutions Corp. (?BIOX?) which forms part of the Registration Statement on Form F-4 of BIOX (the ?Registration Statement?). Dear Members

May 9, 2022 F-4

As filed with the Securities and Exchange Commission on May 9, 2022.

As filed with the Securities and Exchange Commission on May 9, 2022. Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bioceres Crop Solutions Corp. (Exact name of Registrant as Specified in its articles of association)* N/A (Translation of registrant name into English) Cayman Isl

April 29, 2022 EX-99.1

Bioceres Crop Solutions Announces Regulatory Approval of HB4® Soy in China China´s Ministry of Agriculture clearance enables import of soybeans produced using Bioceres´ drought tolerance HB4® technology

Exhibit 99.1 Bioceres Crop Solutions Announces Regulatory Approval of HB4? Soy in China China?s Ministry of Agriculture clearance enables import of soybeans produced using Bioceres? drought tolerance HB4? technology ROSARIO, Argentina April 29, 2022 - Bioceres Crop Solutions Corp. (?Bioceres? or the ?Company?) (NASDAQ: BIOX), a fully-integrated global provider of crop productivity solutions design

April 29, 2022 6-K

BIOX’s Form 6-K furnished to the SEC on April 29, 2022, containing a press release announcing regulatory approval of HB4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of April 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (

April 5, 2022 EX-99.1

Joint Filing Agreement

Exhibit 99.1 Joint Filing Agreement In accordance with Rule 13d-1(k) under the Securities and Exchange Act of 1934, the undersigned hereby agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the ordinary shares, $0.0001 par value, of Bioceres Crop Solutions Corp. and further agree that this joint filing agreement be incl

April 5, 2022 SC 13D/A

BIOX / Bioceres Crop Solutions Corp. / Bioceres S.A. - SC 13D/A Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 6)* Bioceres Crop Solutions Corp. (Name of Issuer) Ordinary Shares, $0.0001 par value (Title of Class of Securities) G1117K 114 (CUSIP Number) Gloria Montaron Estrada Executive Director Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (Name, Address a

March 23, 2022 425

Filed by Marrone Bio Innovations, Inc.

Filed by Marrone Bio Innovations, Inc. (Commission File No. 001-36030) Pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed under Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: Marrone Bio Innovations, Inc. (Commission File No.: 001-36030) Date: March 18, 2022 The following is a transcript of a conference presentation that was given

March 17, 2022 425

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of March 2022 Commission File Number: 001-388

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of March 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (

March 17, 2022 425

Filed by

425 1 tm229590d2425.htm 425 Filed by Bioceres Crop Solutions Corp. (Commission File No. 001-38836) Pursuant to Rule 425 under the Securities Act of 1933 And Deemed Filed under Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Bioceres Crop Solutions Corp. 0800 138 2636 | [email protected] Transcript www.incommglobal.com Bioceres Crop Solutions Corporate Update Thursday,

March 17, 2022 EX-99.2

Bioceres Crop Solutions and Marrone Bio Announce Merger Agreement Combined company creates global leader in sustainable agricultural solutions Bioceres obtains commitment for up to $45 million loan facility and conversion of existing convertible note

Exhibit 99.2 Bioceres Crop Solutions and Marrone Bio Announce Merger Agreement Combined company creates global leader in sustainable agricultural solutions Bioceres obtains commitment for up to $45 million loan facility and conversion of existing convertible notes into shares and new term loan facility ROSARIO, Argentina, and RALEIGH, N.C. ? March 16, 2022 ? Bioceres Crop Solutions Corp. (NASDAQ:

March 17, 2022 EX-2.1

Agreement and Plan of Merger, dated as of March 16, 2022, by and among Bioceres Crop Solutions Corp., Marrone Bio Innovations, Inc. and BCS Merger Sub, Inc. (incorporated by reference to Exhibit 2.1 to the registrant’s Form 6-K furnished to the SEC on March 17, 2022).

Exhibit 2.1 CONFIDENTIAL AGREEMENT AND PLAN OF MERGER by and among Bioceres Crop Solutions Corp., BCS Merger Sub, Inc. and Marrone Bio Innovations, Inc. Dated as of March 16, 2022 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS & INTERPRETATIONS 2 Section 1.01 Certain Definitions 2 Section 1.02 Additional Definitions 16 Section 1.03 Certain Interpretations 19 ARTICLE II THE MERGER 20 Section 2.01 The

March 17, 2022 EX-2.1

Agreement and Plan of Merger, dated as of March 16, 2022, by and among Bioceres Crop Solutions Corp., BCS Merger Sub, Inc., and Marrone Bio Innovations, Inc.*

Exhibit 2.1 CONFIDENTIAL AGREEMENT AND PLAN OF MERGER by and among Bioceres Crop Solutions Corp., BCS Merger Sub, Inc. and Marrone Bio Innovations, Inc. Dated as of March 16, 2022 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS & INTERPRETATIONS 2 Section 1.01 Certain Definitions 2 Section 1.02 Additional Definitions 16 Section 1.03 Certain Interpretations 19 ARTICLE II THE MERGER 20 Section 2.01 The

March 17, 2022 EX-99.1

Transaction Support Agreement for Company Securityholders

Exhibit 99.1 Transaction Support Agreement for Company Securityholders This Transaction Support Agreement (this ?Agreement?) is made and entered into as of March 16, 2022, by and among Bioceres Crop Solutions Corp., a Cayman Islands exempted company (?Parent?), BCS Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (?Merger Sub?), and the stockholders of Marrone Bio I

March 17, 2022 EX-99.1

Transaction Support Agreement for Company Securityholders

Exhibit 99.1 Transaction Support Agreement for Company Securityholders This Transaction Support Agreement (this ?Agreement?) is made and entered into as of March 16, 2022, by and among Bioceres Crop Solutions Corp., a Cayman Islands exempted company (?Parent?), BCS Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (?Merger Sub?), and the stockholders of Marrone Bio I

March 17, 2022 6-K

BIOX’s Form 6-K furnished to the SEC on March 17, 2022, relating to the merger agreement, which is referred to as the “Merger 6-K”);

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of March 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (

March 17, 2022 EX-99.2

Bioceres Crop Solutions and Marrone Bio Announce Merger Agreement Combined company creates global leader in sustainable agricultural solutions Bioceres obtains commitment for up to $45 million loan facility and conversion of existing convertible note

Exhibit 99.2 Bioceres Crop Solutions and Marrone Bio Announce Merger Agreement Combined company creates global leader in sustainable agricultural solutions Bioceres obtains commitment for up to $45 million loan facility and conversion of existing convertible notes into shares and new term loan facility ROSARIO, Argentina, and RALEIGH, N.C. ? March 16, 2022 ? Bioceres Crop Solutions Corp. (NASDAQ:

March 17, 2022 425

Filed by

Filed by Bioceres Crop Solutions Corp. (Commission File No. 001-38836) Pursuant to Rule 425 under the Securities Act of 1933 And Deemed Filed und Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Bioceres Crop Solutions Corp. Bioceres Crop Solutions Transaction Presentation This Presentation is for informational purposes only and does not constitute an offer or invitation to s

February 25, 2022 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2022 Commission File Number: 001-

? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argent

February 25, 2022 EX-99.1

BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of December 31, 2021 and June 30, 2021, and for the three-and six-month periods ended December 31, 2021, and 2020.

Table of Contents ? ? ? BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of December 31, 2021 and June 30, 2021, and for the three-and six-month periods ended December 31, 2021, and 2020. ? ? ? ? ? ? ? Table of Contents INDEX ? ? ? Unaudited interim condensed consolidated financial statements as of December 31, 2021, June 30, 2021 and for the three- an

February 14, 2022 SC 13G/A

BIOX / Bioceres Crop Solutions Corp. / 5DPlus Capital Investment Management Co S.A. Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.

February 10, 2022 6-K

BIOX’s Form 6-K furnished to the SEC on February 10, 2022, containing management’s discussion and analysis of results for the period ended December 31, 2021;

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin

December 23, 2021 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of December 2021 Commission File Number: 001-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of December 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin

November 30, 2021 6-K

Form 6-K filed with the Commission on November 30, 2021

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin

November 30, 2021 EX-99.1

BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of September 30, 2021 and June 30, 2021, and for the three-month periods ended September 30, 2021, and 2020.

EX-99.1 2 tm2132584d3ex99-1.htm EXHIBIT 99.1 BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of September 30, 2021 and June 30, 2021, and for the three-month periods ended September 30, 2021, and 2020. INDEX Unaudited interim condensed consolidated financial statements as of September 30, 2021, June 30, 2021 and for the three-month periods ended Septe

November 15, 2021 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2021 Commission File Number: 001-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin

November 10, 2021 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2021 Commission File Number: 001-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin

October 29, 2021 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of October 2021 Commission File Number: 001-3

6-K 1 tm2119115d26k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of October 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosari

October 29, 2021 EX-15.1

Consent of Price Waterhouse & Co. S.R.L., independent registered public accounting firm, with respect to Bioceres Crop Solutions Corp.’s consolidated financial statements [NOTE TO THE PRINTER: PLEASE ADJUST THE DATE OF EXHIBIT 15.1 TO THE FILING DATE, WHICH IS OCTOBER 29, 2021]

Exhibit 15.1 ? CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ? We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-249770) and Form S-8 (No. 333-255635) of Bioceres Crop Solutions Corp. of our report dated September 30, 2021 relating to the financial statements, which appears in this Form 20-F. ? ? /s/ Price Waterhouse & Co. S.R.L. /s/

October 29, 2021 EX-99.1

Bioceres Crop Solutions Corp. holds its 2021 Annual Shareholders’ Meeting

EXHIBIT 99.1 Bioceres Crop Solutions Corp. holds its 2021 Annual Shareholders? Meeting New York, New York / October 27, 2021 - Bioceres Crop Solutions Corp. (?Bioceres Crop Solutions,? the ?Company,? ?we,? ?us? or ?our?) (NASDAQ: BIOX) held its 2021 Annual Shareholders? Meeting (the ?Meeting?) at the Company?s legal counsel?s office in New York, NY and virtually. At the Meeting, the Company?s shar

October 29, 2021 20-F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F

Table of Contents ? ? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

October 29, 2021 EX-12.1

Rule 13a-14(a)/15d-14(a) -– Section 302 - Certification of Chief Executive Officer

Exhibit 12.1 ? CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 ? I, Federico Trucco, certify that: 1. I have reviewed this annual report on Form 20-F of Bioceres Crop Solutions Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or

October 29, 2021 EX-12.2

Rule 13a-14(a)/15d-14(a) -– Section 302 - Certification of Chief Financial Officer

? Exhibit 12.2 ? CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 ? I, Enrique L?pez Lecube, certify that: 1. I have reviewed this annual report on Form 20-F of Bioceres Crop Solutions Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material

October 29, 2021 EX-13.1

18 U.S.C. SECTION 1350 - Section 906 - Certification of Chief Executive Officer

Exhibit 13.1 ? CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 ? In connection with the Annual Report of Bioceres Crop Solutions Corp. (the ?Company?) on Form 20-F for the year ended June 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the ?Report?), the undersigned hereby certifies pursuant t

October 29, 2021 EX-13.2

18 U.S.C. SECTION 1350 - Section 906 - Certification of Chief Financial Officer

Exhibit 13.2 ? CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 ? In connection with the Annual Report of Bioceres Crop Solutions Corp. (the ?Company?) on Form 20-F for the year ended June 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the ?Report?), the undersigned hereby certifies pursuant t

October 15, 2021 EX-99.1

Joint Filing Agreement

Exhibit 99.1 Joint Filing Agreement In accordance with Rule 13d-1(k) under the Securities and Exchange Act of 1934, the undersigned hereby agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the ordinary shares, $0.0001 par value, of Bioceres Crop Solutions Corp. and further agree that this joint filing agreement be incl

October 15, 2021 SC 13D/A

BIOX / Bioceres Crop Solutions Corp. / Bioceres S.A. - SC 13D/A Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 5)* Bioceres Crop Solutions Corp. (Name of Issuer) Ordinary Shares, $0.0001 par value (Title of Class of Securities) G1117K 114 (CUSIP Number) Gloria Montaron Estrada Executive Director Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (Name, Address a

October 7, 2021 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of October 2021 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of October 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina

October 7, 2021 EX-99.1

Convening Notice to the 2021 Annual General Meeting to be held on October 27, 2021 at 10:00 a.m. EDT at 1290 Avenue of the Americas, New York, NY 10104

www.biocerescrops.com Ocampo 210 bis Predio CCT Rosario (2000) Rosario, Santa Fe, Argentina T: (54) 341 4861100 E: [email protected] / [email protected] September 30, 2021 Dear Shareholder, You are cordially invited to attend the 2021 Annual General Meeting (the ?Annual General Meeting?) of Bioceres Crop Solutions Corp. (the ?Company? or ?Bioceres Crop Solutions?) to b

October 4, 2021 SC 13G/A

BIOX / Bioceres Crop Solutions Corp. / 5DPlus Capital Investment Management Co S.A. Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.

September 30, 2021 EX-99.1

BIOCERES CROP SOLUTIONS CORP. Consolidated financial statements as of and for the years ended June 30, 2021, 2020 and 2019.

Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Consolidated financial statements as of and for the years ended June 30, 2021, 2020 and 2019. INDEX Consolidated financial statements as of and for the years ended June 30, 2021, 2020 and 2019. Report of independent registered public accounting firm F-3 Consolidated statements of financial position F-4 Consolidated statements of comprehensive income F-6 C

September 30, 2021 6-K

Form 6-K filed with the Commission on September 30, 2021

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argenti

September 9, 2021 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2021 Commission File Number: 001

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argenti

September 3, 2021 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2021 Commission File Number: 001

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argenti

August 6, 2021 SC 13D/A

BIOX / Bioceres Crop Solutions Corp. / Bioceres S.A. - SC 13D/A Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 4)* Bioceres Crop Solutions Corp. (Name of Issuer) Ordinary Shares, $0.0001 par value (Title of Class of Securities) G1117K 114 (CUSIP Number) Gloria Montaron Estrada Executive Director Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (Name, Address a

August 5, 2021 SC 13D/A

BIOX / Bioceres Crop Solutions Corp. / 5DPlus Capital Investment Management Co S.A. Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D Under The Securities Exchange Act of 1934 (Amendment No.

July 2, 2021 SC 13D/A

BIOX / Bioceres Crop Solutions Corp. / 5DPlus Capital Investment Management Co S.A. Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D Under The Securities Exchange Act of 1934 (Amendment No.

June 1, 2021 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of May 2021 Commission File Number: 001-38836

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of May 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (Ad

June 1, 2021 EX-99.1

BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of March 31, 2021, June 30, 2020 and for the nine-month periods ended March 31, 2021 and 2020.

EX-99.1 2 tm2117492d1ex99-1.htm EXHIBIT 99.1 BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of March 31, 2021, June 30, 2020 and for the nine-month periods ended March 31, 2021 and 2020. BIOCERES CROP SOLUTIONS CORP. INDEX Unaudited interim condensed consolidated financial statements as of March 31, 2021, June 30, 2020 and for the nine-month periods

June 1, 2021 S-8 POS

As filed with the Securities and Exchange Commission on May 28, 2021

As filed with the Securities and Exchange Commission on May 28, 2021 Registration No.

May 13, 2021 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of May 2021 Commission File Number: 001-38836

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of May 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (Ad

April 30, 2021 EX-99.16

Stand Alone Share Option Agreement between the Registrant and Jorge Wagner dated June 18, 2019.

Exhibit 99.16 SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. ?Beneficiary?: Jorge Wagner ?Number of Shares Subject to Option?: 100,000 ordinary shares par value US$ 0.0001 per share ?Option Exercise Price? per each Share Subject to Option: US$ 4.55 ?Date of Grant?: June 18, 2019 ?Vesting Schedule?: Pursuant to Appendix I ?Expiration Date?: October 31, 2029. Under the terms and conditions of

April 30, 2021 EX-99.20

Stand Alone Share Option Agreement between the Registrant and Natalia Zang dated April 14, 2019.

Exhibit 99.20 SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. ?Beneficiary?: Natalia Zang ?Number of Shares Subject to Option?: 100,000 ordinary shares par value US$ 0.0001 per share ?Option Exercise Price? per each Share Subject to Option: US$ 4.55 ?Date of Grant?: April 14, 2019 ?Vesting Schedule?: Pursuant to Appendix I ?Expiration Date?: October 31, 2029. Under the terms and conditions of

April 30, 2021 EX-99.14

Stand Alone Share Option Agreement between the Registrant and Federico Trucco dated June 18, 2019.

Exhibit 99.14 SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. ?Beneficiary?: Federico Trucco ?Number of Shares Subject to Option?: 300,000 ordinary shares par value US$ 0.0001 per share ?Option Exercise Price? per each Share Subject to Option: US$ 4.55 ?Date of Grant?: June 18, 2019 ?Vesting Schedule?: Pursuant to Appendix I ?Expiration Date?: October 31, 2029. Under the terms and conditions

April 30, 2021 EX-99.15

Amendment to Stand Alone Share Option Agreement between the Registrant and Federico Trucco dated January 13, 2020.

Exhibit 99.15 AMENDMENT TO SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. Federico Trucco, as the Beneficiary, and Bioceres Crop Solutions Corp. (the ?Company? and jointly with the Beneficiary referred to as the ?Parties?), having tis principal place of business at Ocampo 210bis, City of Rosario, Province of Santa Fe; and WHEREAS The Beneficiary entered into a Share Option Agreement (the ?Ag

April 30, 2021 EX-99.19

Amendment to Stand Alone Share Option Agreement between the Registrant and Geronimo Watson dated January 13, 2020.

EX-99.19 22 tm212929d5ex99-19.htm EXHIBIT 99.19 Exhibit 99.19 AMENDMENT TO SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. Gerónimo Watson, as the Beneficiary, and Bioceres Crop Solutions Corp. (the “Company” and jointly with the Beneficiary referred to as the “Parties”) having tis principal place of business at Ocampo 210bis, City of Rosario, Province of Santa Fe; and WHEREAS The Beneficiary

April 30, 2021 EX-99.3

Employee Stock Option Plan.

Exhibit 99.3 BIOCERES CROP SOLUTIONS CORP. EMPLOYEE STOCK OPTION PLAN The Bioceres Crop Solutions Corp. Employee Stock Option Plan (this ?Plan?) was approved by the annual shareholders? meeting, dated October 28, 2020 (the ?Effective Date?) to provide an incentive to eligible employees of Bioceres Crop Solutions Corp. (the ?Company?) and its Subsidiaries, who are in a position to influence the per

April 30, 2021 EX-99.4

Stand Alone Share Option Agreement between the Registrant and Kyle Bransfield dated April 14, 2019.

Exhibit 99.4 SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. ?Beneficiary?: Kyle P. Bransfield ?Number of Shares Subject to Option?: 100,000 ordinary shares par value US$ 0.0001 per share ?Option Exercise Price? per each Share Subject to Option: US$ 4.55 ?Date of Grant?: April 14, 2019 ?Vesting Schedule?: Pursuant to Appendix I ?Expiration Date?: October 31, 2029. Under the terms and conditio

April 30, 2021 EX-99.11

Amendment to Stand Alone Share Option Agreement between the Registrant and Ari Freisinger dated January 13, 2020.

Exhibit 99.11 AMENDMENT TO SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. Ari Freisinger, as the Beneficiary, and Bioceres Crop Solutions Corp. (the ?Company? and jointly with the Beneficiary referred to as the ?Parties?), having tis principal place of business at Ocampo 210bis, City of Rosario, Province of Santa Fe; and WHEREAS The Beneficiary entered into a Share Option Agreement (the ?Agr

April 30, 2021 EX-99.8

Stand Alone Share Option Agreement between the Registrant and Gloria Montaron Estrada dated June 18, 2019.

Exhibit 99.8 SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. ?Beneficiary?: Gloria Montaron Estrada ?Number of Shares Subject to Option?: 200,000 ordinary shares par value US$ 0.0001 per share ?Option Exercise Price? per each Share Subject to Option: US$ 4,55 ?Date of Grant?: June 18, 2019 ?Vesting Schedule?: Pursuant to Appendix I ?Expiration Date?: October 31, 2029. Under the terms and cond

April 30, 2021 EX-99.9

Amendment to Stand Alone Share Option Agreement between the Registrant and Gloria Montaron Estrada dated June 6, 2020.

Exhibit 99.9 AMENDMENT TO SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. Gloria Montar?n Estrada, as the Beneficiary, and Bioceres Crop Solutions Corp. (the ?Company? and jointly with the Beneficiary referred to as the ?Parties?), having tis principal place of business at Ocampo 210bis, City of Rosario, Province of Santa Fe; and WHEREAS The Beneficiary entered into a Share Option Agreement (

April 30, 2021 EX-99.12

Stand Alone Share Option Agreement between the Registrant and Enrique Lopez Lecube dated June 18, 2019.

Exhibit 99.12 SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. ?Beneficiary?: Enrique Lopez Lecube ?Number of Shares Subject to Option?: 100,000 ordinary shares par value US$ 0.0001 per share ?Option Exercise Price? per each Share Subject to Option: US$ 4.55 ?Date of Grant?: June 18, 2019 ?Vesting Schedule?: Pursuant to Appendix I ?Expiration Date?: October 31, 2029. Under the terms and condit

April 30, 2021 EX-99.13

Amendment to Stand Alone Share Option Agreement between the Registrant and Enrique Lopez Lecube dated January 13, 2020.

Exhibit 99.13 AMENDMENT TO SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. Enrique Lopez Lecube, as the Beneficiary, and Bioceres Crop Solutions Corp. (the ?Company? and jointly with the Beneficiary referred to as the ?Parties?), having tis principal place of business at Ocampo 210bis, City of Rosario, Province of Santa Fe; and WHEREAS The Beneficiary entered into a Share Option Agreement (th

April 30, 2021 EX-99.6

Stand Alone Share Option Agreement between the Registrant and Carlos Ivan Carmago de Colon dated April 14, 2019.

Exhibit 99.6 SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. ?Beneficiary?: Carlos Ivan Camargo de Col?n ?Number of Shares Subject to Option?: 100,000 ordinary shares par value US$ 0.0001 per share ?Option Exercise Price? per each Share Subject to Option: US$ 4.55 ?Date of Grant?: April 14, 2019 ?Vesting Schedule?: Pursuant to Appendix I ?Expiration Date?: October 31, 2029. Under the terms an

April 30, 2021 EX-99.5

Amendment to Stand Alone Share Option Agreement between the Registrant and Kyle Bransfield dated January 13, 2020.

Exhibit 99.5 AMENDMENT TO SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. Kyle P. Bransfield, as the Beneficiary, and Bioceres Crop Solutions Corp. (the ?Company? and jointly with the Beneficiary referred to as the ?Parties?), having tis principal place of business at Ocampo 210bis, City of Rosario, Province of Santa Fe; and WHEREAS The Beneficiary entered into a Share Option Agreement (the ?

April 30, 2021 EX-99.21

Amendment to Stand Alone Share Option Agreement between the Registrant and Natalia Zang dated January 15, 2020.

Exhibit 99.21 AMENDMENT TO SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. Natalia Zang, as the Beneficiary, and Bioceres Crop Solutions Corp. (the ?Company? and jointly with the Beneficiary referred to as the ?Parties?), having tis principal place of business at Ocampo 210bis, City of Rosario, Province of Santa Fe; and WHEREAS The Beneficiary entered into a Share Option Agreement (the ?Agree

April 30, 2021 EX-99.1

Employee Stock Purchase Plan.

Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. EMPLOYEE STOCK PURCHASE PLAN The Bioceres Crop Solutions Corp. Employee Stock Purchase Plan (this ?Plan?) was approved by the annual shareholders? meeting, dated October 28, 2020 (the ?Effective Date?), to provide an incentive to eligible employees of the Bioceres Crop Solutions Corp. (the ?Company?) and its Subsidiaries. 1. Establishment of Plan The Comp

April 30, 2021 EX-99.10

Stand Alone Share Option Agreement between the Registrant and Ari Freisinger dated April 14, 2019.

Exhibit 99.10 SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. ?Beneficiary?: Ari Freisinger ?Number of Shares Subject to Option?: 100,000 ordinary shares par value US$ 0.0001 per share ?Option Exercise Price? per each Share Subject to Option: US$ 4.55 ?Date of Grant?: April 14, 2019 ?Vesting Schedule?: Pursuant to Appendix I ?Expiration Date?: October 31, 2029. Under the terms and conditions

April 30, 2021 EX-99.17

Amendment to Stand Alone Share Option Agreement between the Registrant and Jorge Wagner dated February 02, 2020.

Exhibit 99.17 AMENDMENT TO SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. Jorge Wagner, as the Beneficiary, and Bioceres Crop Solutions Corp. (the ?Company? and jointly with the Beneficiary referred to as the ?Parties?), having tis principal place of business at Ocampo 2 Obis, City of Rosario, Province of Santa Fe; and WHEREAS The Beneficiary entered into a Share Option Agreement (the ?Agree

April 30, 2021 EX-99.7

Amendment to Stand Alone Share Option Agreement between the Registrant and Carlos Ivan Carmago de Colon dated January 27, 2020.

EX-99.7 10 tm212929d5ex99-7.htm EXHIBIT 99.7 Exhibit 99.7 AMENDMENT TO SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. Carlos Ivan Camargo de Colón, as the Beneficiary, and Bioceres Crop Solutions Corp. (the “Company” and jointly with the Beneficiary referred to as the “Parties”), having tis principal place of business at Ocampo 210bis, City of Rosario, Province of Santa Fe; and WHEREAS The B

April 30, 2021 EX-99.2

Equity Compensation Plan.

Exhibit 99.2 BIOCERES CROP SOLUTIONS CORP. EQUITY COMPENSATION PLAN The Bioceres Crop Solutions Corp. Equity Compensation Plan (the ?Plan?) was approved by the annual shareholders? meeting, dated October 31, 2019 (the ?Effective Date?), to provide long-term incentive compensation to the executive directors of the Board of Directors and certain key management members of Bioceres Crop Solutions Corp

April 30, 2021 EX-99.18

Stand Alone Share Option Agreement between the Registrant and Geronimo Watson dated June 18, 2019.

Exhibit 99.18 SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. ?Beneficiary?: Ger?nimo Watson ?Number of Shares Subject to Option?: 100,000 ordinary shares par value US$ 0.0001 per share ?Option Exercise Price? per each Share Subject to Option: US$ 4.55 ?Date of Grant?: June 18, 2019 ?Vesting Schedule?: Pursuant to Appendix I ?Expiration Date?: October 31, 2029. Under the terms and conditions

April 30, 2021 S-8

Form S-8 (Registration No. 333-255635)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bioceres Crop Solutions Corp. (Exact name of registrant as specified in its charter) The Cayman Islands (State or other jurisdiction of incorporation or organization) N/A (I.R.S. Employer Identification No.) Ocampo 210 bis, Predio CCT, Rosario Province of Santa F

April 26, 2021 25

- FORM 25

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. NYSE American (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered) Ocampo 2

April 26, 2021 8-A12B

- 8-A12B

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 BIOCERES CROP SOLUTIONS CORP. (Exact name of Registrant as specified in Its Charter) Cayman Islands (State or other jurisdiction of incorporation or organization) Not Applicable (I.R.S. Employer Id

April 14, 2021 6-K

Current Report of Foreign Issuer - FORM 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of April 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (

April 14, 2021 EX-99.1

Bioceres Crop Solutions Announces Transfer to Nasdaq Stock Market

Exhibit 99.1 Bioceres Crop Solutions Announces Transfer to Nasdaq Stock Market ROSARIO, Argentina - April 14, 2021 - Bioceres Crop Solutions Corp. (?Bioceres? or the ?Company?) (NYSE American: BIOX), a fully-integrated global provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, announced today that it will voluntarily transfer its stoc

March 16, 2021 6-K

Current Report of Foreign Issuer - FORM 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of March 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (

March 4, 2021 6-K

Current Report of Foreign Issuer - FORM 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of March 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (

February 26, 2021 EX-99.1

BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of December 31, 2020, June 30, 2020 and for the six-month periods ended December 31, 2020 and 2019.

Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of December 31, 2020, June 30, 2020 and for the six-month periods ended December 31, 2020 and 2019. BIOCERES CROP SOLUTIONS CORP. INDEX Unaudited interim condensed consolidated financial statements as of December 31, 2020, June 30, 2020 and for the six-month periods ended December 31, 2020 a

February 26, 2021 6-K

(c) the Registrant’s Report on Form 6-K filed with the Commission on February 26, 2021; and

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin

February 16, 2021 SC 13G/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)*

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.

Other Listings
DE:0G4 €1.81
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista